Literature DB >> 24378842

Immune evasion: Mycobacteria hide from TLRs.

Elisabeth Kugelberg.   

Abstract

Mesh：

Substances：

Year:  2013        PMID： 24378842     DOI： 10.1038/nri3604

Source DB:  PubMed          Journal:  Nat Rev Immunol        ISSN： 1474-1733            Impact factor:   53.106


× No keyword cloud information.
  1 in total

1.  Mycobacteria manipulate macrophage recruitment through coordinated use of membrane lipids.

Authors:  C J Cambier; Kevin K Takaki; Ryan P Larson; Rafael E Hernandez; David M Tobin; Kevin B Urdahl; Christine L Cosma; Lalita Ramakrishnan
Journal:  Nature       Date:  2013-12-15       Impact factor: 49.962
  1 in total
  5 in total

Review 1.  TLRs in Mycobacterial Pathogenesis: Black and White or Shades of Gray.

Authors:  Priyanka Mehta; Atish Ray; Shibnath Mazumder
Journal:  Curr Microbiol       Date:  2021-04-12       Impact factor: 2.188

2.  RAIRS2 a new expert system for diagnosing tuberculosis with real-world tournament selection mechanism inside artificial immune recognition system.

Authors:  Mahmoud Reza Saybani; Shahaboddin Shamshirband; Shahram Golzari; Teh Ying Wah; Aghabozorgi Saeed; Miss Laiha Mat Kiah; Valentina Emilia Balas
Journal:  Med Biol Eng Comput       Date:  2015-06-17       Impact factor: 2.602

3.  Diagnosing tuberculosis with a novel support vector machine-based artificial immune recognition system.

Authors:  Mahmoud Reza Saybani; Shahaboddin Shamshirband; Shahram Golzari Hormozi; Teh Ying Wah; Saeed Aghabozorgi; Mohamad Amin Pourhoseingholi; Teodora Olariu
Journal:  Iran Red Crescent Med J       Date:  2015-04-25       Impact factor: 0.611

4.  Mycobacterium tuberculosis Peptidyl-Prolyl Isomerases Also Exhibit Chaperone like Activity In-Vitro and In-Vivo.

Authors:  Saurabh Pandey; Ashish Sharma; Deeksha Tripathi; Ashutosh Kumar; Mohd Khubaib; Manish Bhuwan; Tapan Kumar Chaudhuri; Seyed Ehtesham Hasnain; Nasreen Zafar Ehtesham
Journal:  PLoS One       Date:  2016-03-16       Impact factor: 3.240

Review 5.  Host-Pathogen Interaction as a Novel Target for Host-Directed Therapies in Tuberculosis.

Authors:  Rodrigo Abreu; Pramod Giri; Fred Quinn
Journal:  Front Immunol       Date:  2020-07-21       Impact factor: 7.561
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.